Note 16 - Segment and Geographic Information

3 Months Ended

Aug. 31, 2015

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

16. SEGMENT AND GEOGRAPHIC INFORMATION

The Company determines operating segments in accordance with its internal operating structure, which is organized based upon product groups. Each segment is separately managed and is evaluated primarily upon operating results. The Company has two operating segments, the Transfusion segment and the Transplant & Molecular segment, which have been aggregated into one reportable segment.

The Company manufactures and markets a complete line of diagnostics products and automated systems used primarily by hospitals, donor centers and reference laboratories in a number of tests performed to detect and identify certain properties of human blood and human tissue to enable the most compatible match available between patient and donor. These tests are performed for the purpose of blood transfusion, pre-transplant human leukocyte antigen (“HLA”) typing and screening processes as well as post-transplant patient monitoring to aid in the identification of graft rejection.

The Company operates in various geographies. These geographic markets are comprised of the United States, Europe, Canada, Japan and other international markets. These other international markets are considered Emerging Markets for our business. These products are marketed globally, both directly to the end user and through established distributors.

Accounting policies for segments are the same as those described in the summary of significant accounting policies.

The following is a summary of the Company’s segment data (in thousands):

	Three Months Ended
	August 31
	2015		2014
Net sales by product group:
Transfusion	$	81,156		86,369
Transplant & Molecular		15,556		16,072
Total	$	96,712		102,441

Following is a summary of enterprise-wide information (in thousands):

	Three Months Ended
	August 31
	2015		2014
Net sales to customers by geography are as follows:
United States	$	61,422		62,379
Europe (A)		17,787		21,447
Canada		3,899		4,891
Other		13,604		13,724
Total	$	96,712		102,441

Net sales are attributed to individual countries based on the customer’s country of origin at the time of the sale and where the Company has an operating entity.

	As of
	August 31, 2015		May 31, 2015
Long-lived assets (excluding goodwill and intangibles) by geography:
United States	$	52,737		52,764
Europe (B)		14,527		14,542
Canada		3,700		4,029
Other (C)		2,376		2,239
Total	$	73,340		73,574

	As of
	August 31, 2015		May 31, 2015
Concentration of net assets by geography:
United States	$	233,419	$	241,522
Europe		103,265		100,071
Canada		28,808		30,274
Other (C)		11,944		11,814
Total	$	377,436		383,681

(A) – Net sales to any individual country within Europe were not material to the Company’s consolidated net sales.

(B) - Long-lived assets located in any individual country within Europe were not material to the Company's consolidated long-lived assets.

(C) - Primarily Japan and India.

Sales to an individual customer did not exceed more than 10% of our net sales during the three months ended August 31, 2015, or August 31, 2014.